Shay Capital »

Genes shares owned by Shay Capital

Quarter-by-quarter ownership of Genes (GCO) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by Shay Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0M 67k 28.99
2025-09-30 $1.6M 55k 28.99
2025-06-30 $4.0M 205k 19.69

More positions owned by Shay Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ftai Aviation SHS (FTAI)
Purecycle Technologies (PCT)
Meta Platforms Cl A (META)
Micron Technology (MU)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Russell 2000 Etf (IWM)
Thermo Fisher Scientific (TMO)
Papa John's Int'l (PZZA)
Celsius Hldgs Com New (CELH)
Intel Corporation (INTC)
Golar Lng SHS (GLNG)
Core Scientific (CORZ)
Amazon (AMZN)

View all positions for Shay Capital

Top funds holding Genes

Pzena Investment Management
BlackRock
Vanguard Group
Dimensional Fund Advisors
Vanguard Capital Management
Acadian Asset Management
Fund 1 Investments
Charles Schwab Investment Management
Citadel Advisors
Healthcare Of Ontario Pension Plan Trust Fund
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Kingdon Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Genes